Suchergebnisse - "De Leeuw, Elisabeth"

PubPharm (14)

1

Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment

enthalten in: Cell reports. Medicine | 2022

von Bosteels, C. | Van Damme, K. | De Leeuw, E. | +30

2

Inflammasomes and IL-1 family cytokines in SARS-CoV-2 infection : from prognostic marker to therapeutic agent

enthalten in: Cytokine | 2022

von Declercq, J. | De Leeuw, E. | Lambrecht, B.

3

Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19 : an open-label randomized controlled trial

enthalten in: Respiratory research | 2022

von De Leeuw, E. | Van Damme, K. | Declercq, J. | +25

4

Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial

enthalten in: Respiratory research | 2022

von De Leeuw, E. | Van Damme, K. | Declercq, J. | +25

5

Zilucoplan in patients with acute hypoxic respiratory failure due to COVID-19 (ZILU-COV) : A structured summary of a study protocol for a randomised controlled trial

enthalten in: Trials | 2020

von Declercq, J. | Bosteels, C. | Van Damme, K. | +18

6

Zilucoplan in patients with acute hypoxic respiratory failure due to COVID-19 (ZILU-COV): A structured summary of a study protocol for a randomised controlled trial

enthalten in: Trials | 2020

von Declercq, J. | Bosteels, C. | Van Damme, K. | +18

7

Zilucoplan in patients with acute hypoxic respiratory failure due to COVID-19 (ZILU-COV): A structured summary of a study protocol for a randomised controlled trial

enthalten in: Trials | 2020

von Declercq, J. | Bosteels, C. | Van Damme, K. | +18

8

Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC) : A structured summary of a study protocol for a randomised controlled trial

enthalten in: Trials | 2020

von Bosteels, C. | Maes, B. | Van Damme, K. | +14

ErratumIn: Trials. 2020 Jun 22;21(1):554. - PMID 32571428

9

Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trial

enthalten in: Trials | 2020

von Bosteels, C. | Maes, B. | Van Damme, K. | +14

10

Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trial

enthalten in: Trials | 2020

von Bosteels, C. | Maes, B. | Van Damme, K. | +14